Scrutinizer Report Attached along with voting results of 40th AGM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech Limited held its 40th Annual General Meeting on 30th September 2025 via video conferencing. Four resolutions were put to vote, all of which were passed with overwhelming majority (99.99% in favour). The resolutions included adoption of audited financial statements for FY ended 31st March 2025, re-appointment of Mrs. Brij Bala Gupta (DIN: 00975261) as Director retiring by rotation, re-appointment of Mr. Amit Kumar as Manager (KMP), and adoption of the Memorandum of Association as per the Companies Act, 2013 (special resolution). Out of 3,966 total shareholders, 84 members cast their votes through remote e-voting while none voted at the AGM. The promoter group (holding 16,09,944 shares) voted 100% in favour, while public shareholders (holding 13,90,356 shares) voted 93.69% in favour and 6.31% against.
All resolutions passed smoothly with near-unanimous support, indicating stable promoter control and no significant shareholder dissent. The clean approval of director re-appointments and the MoA adoption suggests routine corporate housekeeping with no material governance concerns for investors.